𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Botulinum toxin injections reduce associative plasticity in patients with primary dystonia

✍ Scribed by Maja Kojovic; Antonio Caronni; Matteo Bologna; John C. Rothwell; Kailash P. Bhatia; Mark J. Edwards


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
373 KB
Volume
26
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Botulinum toxin injections ameliorate dystonic symptoms by blocking the neuromuscular junction and weakening dystonic contractions. We asked if botulinum toxin injections in dystonia patients might also affect the integrity of sensorimotor cortical plasticity, one of the key pathophysiological features of dystonia. We applied a paired associative stimulation protocol, known to induce long‐term potentiation–like changes in the primary motor cortex hand area to 12 patients with cervical dystonia before and 1 and 3 months after botulinum toxin injections to the neck muscles. Primary motor cortex excitability was probed by measuring transcranial magnetic stimulation‐evoked motor evoked potentials before and after paired associative stimulation. We also measured the input–output curve, short‐interval intracortical inhibition, intracortical facilitation, short afferent inhibition, and long afferent inhibition in hand muscles and the clinical severity of dystonia. Before botulinum toxin injections, paired associative stimulation significantly facilitated motor evoked potentials in hand muscles. One month after injections, this effect was abolished, with partial recovery after 3 months. There were significant positive correlations between the facilitation produced by paired associative stimulation and (1) the time elapsed since botulinum toxin injections and (2) the clinical dystonia score. One effect of botulinum toxin injection treatment is to modulate afferent input from the neck. We propose that subsequent reorganization of the motor cortex representation of hand muscles may explain the effect of botulinum toxin on motor cortical plasticity. © The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.


📜 SIMILAR VOLUMES


A rare case of laryngeal dystonia associ
✍ Ki-Hong Kevin Ho; Christopher C. Wright; Michael P. Underbrink 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

## Abstract We report a unique case of laryngeal dystonia in a 43‐year‐old male with neurosyphilis who underwent successful treatment with botulinum toxin injection. To date there have been no reports of laryngeal dystonia associated with neurosyphilis. The patient initially presented with strained

Use of botulinum toxin type F injections
✍ Dr. Paul E. Greene; Stanley Fahn 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 492 KB

## Abstract Fifteen patients with torticollis who had been treated with repeated injections of botulinum toxin type A (botox A) developed antibodies to the toxin. This resulted in loss of benefit in the 13 patients who had improved with botox A injections and failure to develop muscle atrophy after

Secondary nonresponsiveness to botulinum
✍ Charles H. Adler; Stewart A. Factor; Mitchell Brin; Kapil D. Sethi 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

## Abstract Intramuscular injection of botulinum toxin type A is the treatment of choice for most cases of oromandibular dystonia. We report on five patients with oromandibular dystonia that developed secondary nonresponsiveness to botulinum toxin type A following multiple injections over a 6‐year

Long-term botulinum toxin treatment incr
✍ Inger Marie Skogseid; Jo Røislien; Bjørgulf Claussen; Emilia Kerty 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

## Abstract We examined the impact of cervical dystonia (CD) and long‐term botulinum toxin (BTX) treatment on employment status. Data on employment status at onset of CD, at initiation of BTX treatment, and at evaluation of long‐term treatment were obtained from 62 CD patients aged 31–66 years (med